Adbry (tralokinumab-ldrm)

Adult Dosing .

Dosage forms:  INJ (auto-injector): 300 mg; INJ (pre-filled syringe): 150 mg per mL

Special Note

[formulation clarification]

Info: nonproprietary name = tralokinumab-ldrm

atopic dermatitis, moderate-severe

[300 mg SC q2wk]

Start: 600 mg SC x1; Info: may consider 300 mg SC q4wk after 16wk if wt <100 kg

renal dosing

[see below]

mild-moderate impairment: no adjustment; severe impairment: not defined

HD/PD: not defined

hepatic dosing

[see below]

mild impairment: no adjustment; moderate-severe impairment: not defined

Peds Dosing .

Dosage forms:  INJ (pre-filled syringe): 150 mg per mL

Special Note

[formulation clarification]

Info: nonproprietary name = tralokinumab-ldrm

atopic dermatitis, moderate-severe

[12-17 yo]

Dose: 150 mg SC q2wk; Start: 300 mg SC x1

renal dosing

[not defined]

renal impairment: consider adult renal dosing for guidance

HD/PD: not defined

hepatic dosing

[not defined]

hepatic impairment: consider adult hepatic dosing for guidance